TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $718,136,000 | -24.2% | 39,458 | -25.7% | 0.51% | -17.2% |
Q3 2020 | $947,161,000 | -0.5% | 53,092 | 0.0% | 0.62% | -36.7% |
Q2 2020 | $951,940,000 | +18.1% | 53,092 | 0.0% | 0.98% | -37.6% |
Q1 2020 | $805,937,000 | -23.1% | 53,092 | 0.0% | 1.57% | +22.1% |
Q4 2019 | $1,047,505,000 | -2.8% | 53,092 | -15.2% | 1.29% | +55.6% |
Q3 2019 | $1,077,374,000 | -78.3% | 62,638 | -77.6% | 0.83% | -62.4% |
Q2 2019 | $4,956,000,000 | -43.5% | 280,000 | -34.9% | 2.20% | -48.4% |
Q1 2019 | $8,766,617,000 | -44.2% | 430,369 | -53.9% | 4.26% | -53.7% |
Q4 2018 | $15,700,898,000 | – | 933,466 | – | 9.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |